Sanjay Shukla - May 21, 2021 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
President and CEO, Director
Signature
Nancy Denyes, attorney-in-fact
Stock symbol
LIFE
Transactions as of
May 21, 2021
Transactions value $
$0
Form type
4
Date filed
5/25/2021, 09:03 PM
Previous filing
May 20, 2021
Next filing
Nov 15, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Employee Stock Option (Right to buy) Award $0 +207K $0.00 207K May 21, 2021 Common Stock 207K $4.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.